foxo4-dri senolytic peptide human trial

foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound foxo4-dri senolytic peptide – Development of a novel senolytic

Name: foxo4-dri senolytic peptide human trial 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound foxo4-dri senolytic peptide – Development of a novel senolytic
Brand: actil.am
SKU: 57587141293
Price: 24.36 USD
Availability: InStock
Rating: 4.6066 (21 reviews)

SKU: 57587141293

4.6

USD24.36 USD67.36

Pay in 4 interest-free payments of $6.09 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 28 - Sep 2

Description

Price range: $55 through $170 Our products are provided in a freeze-dried, lyophilized powder that is vacuum sealed in a sterile vial format that typically require reconstitution with an applicable solvent or solution and intended for research use only